Corvia Medical Closes $54 Million Financing To Support Planned Confirmatory Trial Of The Corvia® Atrial Shunt
Corvia Medical Closes $54 Million Financing To Support Planned Confirmatory Trial Of The Corvia® Atrial Shunt
06/09/22, 7:03 AM
Location
Money raised
$54 million
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced the closing of a $54 million equity financing from its existing investor syndicate. Funds will be utilized to support a confirmatory trial that builds on the extensive data and progressive learnings from the REDUCE LAP-HF II clinical trial of the Corvia® Atrial Shunt in heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction.